73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Localizing BRCA gene mutations to better treat ovarian cancer

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n
Study shows older age and smoking most important risk factors for developing any cancer

Study shows older age and smoking most important risk factors for developing any cancer

byAmerican Cancer SocietyCredit: Unsplash/CC0 Public DomainA new large study led by researchers at the American Cancer Society (ACS) shows older age and smoking are the two most important risk f

Study shows older age and smoking most important risk factors for developing any cancer

byAmerican Cancer SocietyCredit: Unsplash/CC0 Public DomainA new large study led by researchers at the American Cancer Society (ACS) shows older age and smoking are the two most important risk f
Team learns how to predict triple negative breast cancer recurrence

Team learns how to predict triple negative breast cancer recurrence

byIndiana University School of MedicineCredit: Anna CarreraIndiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and

Team learns how to predict triple negative breast cancer recurrence

byIndiana University School of MedicineCredit: Anna CarreraIndiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and
Australian research shows rates of obesity-related cancers quadrupled in a generation

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi
Results mixed for twice-daily APBI in early breast cancer

Results mixed for twice-daily APBI in early breast cancer

(HealthDay)—Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recu

Results mixed for twice-daily APBI in early breast cancer

(HealthDay)—Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recu
Cancer Gene Census paves the way for improvements in personalised medicine

Cancer Gene Census paves the way for improvements in personalised medicine

byWellcome Trust Sanger InstituteCredit: Wellcome Trust Sanger InstituteResearchers at the Wellcome Sanger Institute have created the first comprehensive summary of all genes known to be involve

Cancer Gene Census paves the way for improvements in personalised medicine

byWellcome Trust Sanger InstituteCredit: Wellcome Trust Sanger InstituteResearchers at the Wellcome Sanger Institute have created the first comprehensive summary of all genes known to be involve
Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients
Slit2 signaling stimulates Ewing sarcoma growth

Slit2 signaling stimulates Ewing sarcoma growth

by Impact Journals LLCEWS::FLI1 binds to the Slit2 gene promoter in Ewing sarcoma cells. Credit: 2022 Suvarna et al.A new research paper was published inGenes & Canceron December 14, 2

Slit2 signaling stimulates Ewing sarcoma growth

by Impact Journals LLCEWS::FLI1 binds to the Slit2 gene promoter in Ewing sarcoma cells. Credit: 2022 Suvarna et al.A new research paper was published inGenes & Canceron December 14, 2
Promising approach to mitigate complications of leukemia treatment

Promising approach to mitigate complications of leukemia treatment

by Molly Chiu,Baylor College of MedicineChronic meyloid leukemia under a microscope. Credit: Baylor College of MedicineResearchers at Baylor College of Medicine and collaborating institutions ha

Promising approach to mitigate complications of leukemia treatment

by Molly Chiu,Baylor College of MedicineChronic meyloid leukemia under a microscope. Credit: Baylor College of MedicineResearchers at Baylor College of Medicine and collaborating institutions ha
Overall cancer mortality continued to decline from 2019 to 2020

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America
HER2+ early breast cancers where shorter-course trastuzumab could be an option

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r
How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapybyLudwig Cancer ResearchCredit: CC0 Public DomainA team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and a

How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapybyLudwig Cancer ResearchCredit: CC0 Public DomainA team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and a